Literature DB >> 26401706

Central Nervous System Delivery of Intranasal Insulin: Mechanisms of Uptake and Effects on Cognition.

Therese S Salameh1,2, Kristin M Bullock1, Isabel A Hujoel1, Michael L Niehoff3,4, Tami Wolden-Hanson1, Junghyun Kim3, John E Morley3, Susan A Farr3,4, William A Banks1,2.   

Abstract

Intranasal insulin has shown efficacy in patients with Alzheimer's disease (AD), but there are no preclinical studies determining whether or how it reaches the brain. Here, we showed that insulin applied at the level of the cribriform plate via the nasal route quickly distributed throughout the brain and reversed learning and memory deficits in an AD mouse model. Intranasal insulin entered the blood stream poorly and had no peripheral metabolic effects. Uptake into the brain from the cribriform plate was saturable, stimulated by PKC inhibition, and responded differently to cellular pathway inhibitors than did insulin transport at the blood-brain barrier. In summary, these results show intranasal delivery to be an effective way to deliver insulin to the brain.

Entities:  

Keywords:  Alzheimer’s disease; cognition; insulin; intranasal administration

Mesh:

Substances:

Year:  2015        PMID: 26401706      PMCID: PMC6080853          DOI: 10.3233/JAD-150307

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  44 in total

1.  Intranasal insulin improves memory in humans.

Authors:  Christian Benedict; Manfred Hallschmid; Astrid Hatke; Bernd Schultes; Horst L Fehm; Jan Born; Werner Kern
Journal:  Psychoneuroendocrinology       Date:  2004-11       Impact factor: 4.905

Review 2.  Brain metabolic dysfunction at the core of Alzheimer's disease.

Authors:  Suzanne M de la Monte; Ming Tong
Journal:  Biochem Pharmacol       Date:  2013-12-28       Impact factor: 5.858

3.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

Authors:  Konrad Talbot; Hoau-Yan Wang; Hala Kazi; Li-Ying Han; Kalindi P Bakshi; Andres Stucky; Robert L Fuino; Krista R Kawaguchi; Andrew J Samoyedny; Robert S Wilson; Zoe Arvanitakis; Julie A Schneider; Bryan A Wolf; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  J Clin Invest       Date:  2012-04       Impact factor: 14.808

4.  A single-dose pilot trial of intranasal rapid-acting insulin in apolipoprotein E4 carriers with mild-moderate Alzheimer's disease.

Authors:  Michael H Rosenbloom; Terry R Barclay; Maria Pyle; Brian L Owens; Amanda B Cagan; Christopher P Anderson; William H Frey; Leah R Hanson
Journal:  CNS Drugs       Date:  2014-12       Impact factor: 5.749

5.  Central and peripheral administration of antisense oligonucleotide targeting amyloid-β protein precursor improves learning and memory and reduces neuroinflammatory cytokines in Tg2576 (AβPPswe) mice.

Authors:  Susan A Farr; Michelle A Erickson; Michael L Niehoff; William A Banks; John E Morley
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

6.  Effects of single dose intranasal oxytocin on social cognition in schizophrenia.

Authors:  Michael C Davis; Junghee Lee; William P Horan; Angelika D Clarke; Mark R McGee; Michael F Green; Stephen R Marder
Journal:  Schizophr Res       Date:  2013-05-12       Impact factor: 4.939

7.  Effect of PAO (phenylarsine oxide) on the inhibitory effect of insulin and IGF-1 on insulin release from INS-1 cells.

Authors:  Eugen J Verspohl
Journal:  Endocr J       Date:  2006-02       Impact factor: 2.349

Review 8.  New roles for insulin-like hormones in neuronal signalling and protection: new hopes for novel treatments of Alzheimer's disease?

Authors:  Christian Hölscher; Lin Li
Journal:  Neurobiol Aging       Date:  2008-10-18       Impact factor: 4.673

9.  On the delay-dependent involvement of the hippocampus in object recognition memory.

Authors:  Rebecca S Hammond; Laura E Tull; Robert W Stackman
Journal:  Neurobiol Learn Mem       Date:  2004-07       Impact factor: 2.877

10.  Differential permeability of the blood-brain barrier to two pancreatic peptides: insulin and amylin.

Authors:  W A Banks; A J Kastin
Journal:  Peptides       Date:  1998       Impact factor: 3.750

View more
  38 in total

Review 1.  Routes for the delivery of insulin to the central nervous system: A comparative review.

Authors:  Elizabeth M Rhea; Therese S Salameh; William A Banks
Journal:  Exp Neurol       Date:  2018-11-27       Impact factor: 5.330

2.  Long-Term Intranasal Insulin Aspart: A Profile of Gene Expression, Memory, and Insulin Receptors in Aged F344 Rats.

Authors:  Hilaree N Frazier; Adam O Ghoweri; Emily Sudkamp; Eleanor S Johnson; Katie L Anderson; Grant Fox; Keomany Vatthanaphone; Mengfan Xia; Ruei-Lung Lin; Kendra E Hargis-Staggs; Nada M Porter; James R Pauly; Eric M Blalock; Olivier Thibault
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-05-22       Impact factor: 6.053

Review 3.  The therapeutic potential of metabolic hormones in the treatment of age-related cognitive decline and Alzheimer's disease.

Authors:  John Grizzanti; Hyoung-Gon Lee; Antoni Camins; Merce Pallas; Gemma Casadesus
Journal:  Nutr Res       Date:  2016-11-08       Impact factor: 3.315

4.  Combination of Insulin with a GLP1 Agonist Is Associated with Better Memory and Normal Expression of Insulin Receptor Pathway Genes in a Mouse Model of Alzheimer's Disease.

Authors:  Ari Robinson; Irit Lubitz; Dana Atrakchi-Baranes; Avital Licht-Murava; Pavel Katsel; Derek Leroith; Sigal Liraz-Zaltsman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  J Mol Neurosci       Date:  2019-01-11       Impact factor: 3.444

5.  Insulin transport across the blood-brain barrier can occur independently of the insulin receptor.

Authors:  Elizabeth M Rhea; Christian Rask-Madsen; William A Banks
Journal:  J Physiol       Date:  2018-08-28       Impact factor: 5.182

6.  The SAMP8 mouse for investigating memory and the role of insulin in the brain.

Authors:  Elizabeth M Rhea; William A Banks
Journal:  Exp Gerontol       Date:  2016-12-12       Impact factor: 4.032

Review 7.  Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer's disease.

Authors:  Therese S Salameh; Elizabeth M Rhea; William A Banks; Angela J Hanson
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-28

8.  Expression of a Constitutively Active Human Insulin Receptor in Hippocampal Neurons Does Not Alter VGCC Currents.

Authors:  H N Frazier; K L Anderson; S Maimaiti; A O Ghoweri; S D Kraner; G J Popa; K K Hampton; M D Mendenhall; C M Norris; R J Craven; O Thibault
Journal:  Neurochem Res       Date:  2018-03-23       Impact factor: 3.996

Review 9.  Cerebral cortex: a target and source of insulin?

Authors:  Éva A Csajbók; Gábor Tamás
Journal:  Diabetologia       Date:  2016-05-20       Impact factor: 10.122

10.  Impact of Single or Repeated Dose Intranasal Zinc-free Insulin in Young and Aged F344 Rats on Cognition, Signaling, and Brain Metabolism.

Authors:  Katie L Anderson; Hilaree N Frazier; Shaniya Maimaiti; Vikas V Bakshi; Zana R Majeed; Lawrence D Brewer; Nada M Porter; Ai-Ling Lin; Olivier Thibault
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-04-10       Impact factor: 6.053

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.